Jocelyn Ashford is the Head of Cardiorenal Global Patient Advocacy at BridgeBio, a clinical-stage biopharmaceutical company focused on genetic diseases and cancers with clear genetic drivers. She is dedicated to strengthening relationships with patient advocacy organizations and the broader community. Before joining the BridgeBio family, Jocelyn was at Genentech where she led advocacy relations efforts to address the unmet needs in various rare and not-so-rare Respiratory and Immunology communities.

Jocelyn holds a Bachelor’s in Industrial Engineering & Economics. She completed her Master’s work in Engineering Management and Social & Organizational Change at Northwestern University in Evanston, IL.